Federal grants to Oleolive, Inc.
Oleolive, Inc. in Shreveport, Louisiana received $3.5 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Aging Research, with $2.7 million. In fiscal 2025 it was awarded $309,418.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$3.5 million
- Awards4
- Awarded in FY 2025$309,418
- Largest award$2.7 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $51,632 |
| FY 2022 | 2 | $2.1 million |
| FY 2023 | 1 | $1.0 million |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $309,418 |
Programs that fund Oleolive, Inc.
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 1 | $2.7 million |
| Cancer Treatment Research | 2 | $439,521 |
| Allergy and Infectious Diseases Research | 1 | $309,418 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $3.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Evaluation of a dual ppar agonist for treatment of alzheimer's disease - summary alzheimer’s disease (AD) is the sixth leading cause of death in united states, affecting 5M people, yet this indication lacks effective therapeutics. The lead co-investigator at the academic performance site has develop | Aging Research | September 9, 2022 | $2.7 million |
| Chemosensitization of glioblastoma by propentofylline - summary glioblastoma (GBM) is the most common primary tumor of the cns with limited treatment options and a poor clinical prognosis. Standard of care treatment, including surgical resection, radiation therapy and concurrent temozolomide (TMZ) t | Cancer Treatment Research | August 9, 2022 | $399,998 |
| Repurposing pyrvinium as an inhalation therapy for idiopathic pulmonary fibrosis - summary idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease that is characterized by progressive decline in lung function due to inflammatory and fibrotic changes of the lung parenchyma. The a | Allergy and Infectious Diseases Research | September 17, 2025 | $309,418 |
| Oleocanthal functional food products for breast cancer recurrence control | Cancer Treatment Research | May 14, 2021 | $39,523 |
Questions people ask
How much federal grant money does Oleolive, Inc. get?
$3.5 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Oleolive, Inc. the most?
The Department of Health and Human Services, with $3.5 million in 4 awards.
What is Oleolive, Inc.'s largest federal grant?
$2.7 million under Aging Research, with its first action in the period on September 9, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Oleolive, Inc.?
Its largest are Aging Research, Cancer Treatment Research and Allergy and Infectious Diseases Research.
Other grant recipients in Shreveport
- Louisiana State University
- Southern University Shreveport
- Caddo Parish of
- Shreveport Transit Management Inc
- Shreveport Regional Airport
- David Raines Community Health Center Inc
- City of Shreveport
- Shreveport Housing Authority
Largest federal grant recipients in Louisiana · Federal grants in Louisiana